Actively Recruiting
Cardiovascular Disease Risk in Women With Endometriosis
Led by Yale University · Updated on 2025-05-23
40
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.
CONDITIONS
Official Title
Cardiovascular Disease Risk in Women With Endometriosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women between 18 and 45 years old without endometriosis (controls)
- Women between 18 and 45 years old with endometriosis
You will not qualify if you...
- Current smokers
- People with diabetes
- People with sleep apnea or blood pressure over 140/90
- Women with endometriosis experiencing severe acute pain that needs immediate treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yale School of Medicine
New Haven, Connecticut, United States, 06519
Actively Recruiting
Research Team
N
Nina Stachenfeld, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here